SCHEMBL15823698

SCHEMBL15823698

COc1cc(C(=O)NCCCCc2ccc(-c3ccccc3)c(NC(=O)O)c2)c(Cl)cc1C=O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 3/20 0.41
POLB P06746 2/20 0.41
SLC6A5 Q9Y345 2/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GFER P55789 1/20 0.39
PLAAT3 P53816 1/20 0.38
PLAAT5 Q96KN8 1/20 0.38
PLAAT2 Q9NWW9 1/20 0.38
PLAAT4 Q9UL19 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15823225 0.97 NPC1 (0.45) NPC1RAB9AKMT2APOLBALDH1A1
SCHEMBL15822284 0.88 NPC1 (0.43) NPC1RAB9AKMT2APOLBSLC6A5
SCHEMBL15823257 0.82 POLB (0.45) NPC1RAB9AKMT2APOLBMEN1
SCHEMBL15822677 0.81 ALDH1A1 (0.41) NPC1RAB9AKMT2APOLBALDH1A1
SCHEMBL17260055 0.80 DRD3 (0.36) NPC1RAB9AKMT2APOLBSLC6A5
SCHEMBL15823422 0.78 KMT2A (0.37) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL17259389 0.76 CACNB4 (0.34) KMT2APOLBSLC6A5MEN1ALDH1A1
SCHEMBL17259390 0.76 CACNB4 (0.34) KMT2APOLBSLC6A5MEN1ALDH1A1
SCHEMBL15823068 0.75 CDK8 (0.39) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL15823668 0.74 ADRB2 (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed